Efficacy and safety of tenalisib, a PI3K δ/γ and SIK3 inhibitor, in patients with locally advanced or metastatic breast cancer: Updated results from an on-going phase II study.
| Autor: | Makharadze, Tamta, Kiladze, Ivane, Dzagnidze, Giorgi, Semionova, Nino, Katselashvili, Lika, Vekua, Natia, Routhu, Kasi V., Barde, Prajak J., Nair, Ajit |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p1064-1064, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|